Discover
IMNM
Immunome, Inc.
22.36
1 x 15.99
4 x 28.09
bid
ask
+
0.87
4.03%
11:25 AM
timesize
| Ytd | 4.07% | |
| 1y | 159.04% |
21.26
day range
22.36
7.96
52 week range
27.65
| Open | 21.60 | Prev Close | 21.49 | Low | 21.26 | High | 22.36 | Mkt Cap | 2.53B |
| Vol | 319.13K | Avg Vol | 1.27M | EPS | -2.39 | P/E | N/A | Forward P/E | -10.25 |
| Beta | 2.07 | Short Ratio | 13.81 | Inst. Own | 108.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 21.08 | 200-d Avg | 19.76 | 1yr Est | 35.77 |
| Income Statement | |||
| Operating Expenses | 59.33M | ||
| Research and Development Expense | 46.38M | ||
| Selling, General and Administrative Expense | 12.95M | ||
| Operating Income | -59.33M | ||
| Net Income | -53.84M | ||
| Net Income Common Stock | -53.84M | ||
| Net Income Common Stock (USD) | -53.84M | ||
| Consolidated Income | -53.84M | ||
| Earnings per Basic Share | -0.48 | ||
| Earnings per Basic Share (USD) | -0.48 | ||
| Earnings per Diluted Share | -0.48 | ||
| Earning Before Interest & Taxes (EBIT) | -53.84M | ||
| Earning Before Interest & Taxes (USD) | -53.84M | ||
| Weighted Average Shares | 113.14M | ||
| Weighted Average Shares Diluted | 113.14M | ||
| Balance Sheet | |||
| Cash and Equivalents | 582.90M | ||
| Cash and Equivalents (USD) | 582.90M | ||
| Current Assets | 594.31M | ||
| Property, Plant & Equipment Net | 19.91M | ||
| Total Assets | 619.79M | ||
| Total Debt | 3.69M | ||
| Current Liabilities | 27.41M | ||
| Debt Non-Current | 3.69M | ||
| Total Liabilities | 31.11M | ||
| Accumulated Retained Earnings (Deficit) | -782.00M | ||
| Shareholders Equity | 588.69M | ||
| Shareholders Equity (USD) | 588.69M | ||
| Assets Non-Current | 25.48M | ||
| Total Debt (USD) | 3.69M | ||
| Liabilities Non-Current | 3.69M | ||
| Trade and Non-Trade Payables | 5.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 753.00K | ||
| Net Cash Flow from Financing | -135.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -70.79M | ||
| Capital Expenditure | -3.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -9.01M | ||
| Issuance (Purchase) of Equity Shares | 229.00K | ||
| Net Cash Flow from Investing | -12.02M | ||
| Net Cash Flow from Operations | -58.64M | ||
| Share Based Compensation | 7.95M | ||